193 related articles for article (PubMed ID: 37327360)
21. Seeking an optimal dose of preoperative corticosteroids in chronic rhinosinusitis with nasal polyposis: A randomized controlled trial.
Kominsky E; Liu KY; Ninan S; Arrighi-Allisan A; Filimonov A; Kidwai S; Morton K; Saini AT; Spock T; Del Signore A; Govindaraj S; Iloreta AM
Am J Otolaryngol; 2022; 43(4):103476. PubMed ID: 35567836
[TBL] [Abstract][Full Text] [Related]
22. The Effect of Corticosteroids on Sinus Microbiota in Chronic Rhinosinusitis Patients with Nasal Polyposis.
Alammar Y; Rousseau S; Desrosiers M; Tewfik MA
Am J Rhinol Allergy; 2023 Nov; 37(6):638-645. PubMed ID: 37475202
[TBL] [Abstract][Full Text] [Related]
23. Olfactory outcomes in chronic rhinosinusitis with nasal polyposis after medical treatments: a systematic review and meta-analysis.
Banglawala SM; Oyer SL; Lohia S; Psaltis AJ; Soler ZM; Schlosser RJ
Int Forum Allergy Rhinol; 2014 Dec; 4(12):986-94. PubMed ID: 25400017
[TBL] [Abstract][Full Text] [Related]
24. Unified Airway Disease: Medical Management.
Shamil E; Hopkins C
Otolaryngol Clin North Am; 2023 Feb; 56(1):157-168. PubMed ID: 36266108
[TBL] [Abstract][Full Text] [Related]
25. A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis.
Brown WC; Senior B
Curr Allergy Asthma Rep; 2020 Apr; 20(6):16. PubMed ID: 32323067
[TBL] [Abstract][Full Text] [Related]
26. Remission in Type 2 Inflammatory Diseases: Current Evidence, Unmet Needs, and Suggestions for Defining Remission in Chronic Rhinosinusitis with Nasal Polyps.
Caminati M; De Corso E; Ottaviano G; Pipolo C; Schiappoli M; Seccia V; Spinelli FR; Savarino EV; Gisondi P; Senna G
Curr Allergy Asthma Rep; 2024 Jan; 24(1):11-23. PubMed ID: 38085499
[TBL] [Abstract][Full Text] [Related]
27. Real-Life Experience of Biologic Treatment for Asthma on Chronic Rhinosinusitis: A Finnish Cohort.
Lyly A; Genberg E; Kauppi P; Virkkula P; Lee SE; Laidlaw TM; Toppila-Salmi S; Lundberg M
Int Arch Allergy Immunol; 2023; 184(2):149-160. PubMed ID: 36349770
[TBL] [Abstract][Full Text] [Related]
28. Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polyps.
Borish L; Cohen NA; Chupp G; Hopkins C; Wagenmann M; Sousa AR; Smith SG; Silver J; Yang S; Mayer B; Yancey SW; Chan RH; Fokkens W
Ann Allergy Asthma Immunol; 2022 Aug; 129(2):160-168. PubMed ID: 35398492
[TBL] [Abstract][Full Text] [Related]
29. Antibody-based therapeutics for chronic rhinosinusitis with nasal polyps.
Shishodia S; Haloob N; Hopkins C
Expert Opin Biol Ther; 2024 Jun; 24(6):491-502. PubMed ID: 38900023
[TBL] [Abstract][Full Text] [Related]
30. [Chronic rhinosinusitis with nasal polyposis : A retrospective analysis of therapeutic approaches in 463 patients].
Strauss J; Lochbaum R; Hoffmann TK; Mayer B; Appel H; Hahn J
HNO; 2024 Jul; 72(7):464-472. PubMed ID: 38700581
[TBL] [Abstract][Full Text] [Related]
31. Current and emerging biological therapies for Chronic rhinosinusitis with nasal polyps with type 2 inflammation.
Jin Z; Yan B; Zhang L; Wang C
Expert Opin Investig Drugs; 2023; 32(10):909-919. PubMed ID: 37855222
[TBL] [Abstract][Full Text] [Related]
32. The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps.
Bachert C; Desrosiers MY; Hellings PW; Laidlaw TM
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1099-1106. PubMed ID: 33227522
[TBL] [Abstract][Full Text] [Related]
33. Use of biologics in chronic sinusitis with nasal polyps.
Wang C; Zhang L
Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):365-372. PubMed ID: 31082822
[TBL] [Abstract][Full Text] [Related]
34. Comparison of guidelines for prescription and follow-up of biologics for chronic rhinosinusitis with nasal polyps.
Rampi A; Vinciguerra A; Tanzini U; Bussi M; Trimarchi M
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):39-46. PubMed ID: 36098864
[TBL] [Abstract][Full Text] [Related]
35. Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis.
Gillespie MB; Osguthorpe JD
Curr Allergy Asthma Rep; 2004 Nov; 4(6):478-85. PubMed ID: 15462715
[TBL] [Abstract][Full Text] [Related]
36. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care.
Hellings PW; Alobid I; Anselmo-Lima WT; Bernal-Sprekelsen M; Bjermer L; Caulley L; Chaker A; Constantinidis J; Conti DM; De Corso E; Desrosiers M; Diamant Z; Gevaert P; Han JK; Heffler E; Hopkins C; Landis BN; Lourenco O; Lund V; Luong AU; Mullol J; Peters A; Philpott C; Reitsma S; Ryan D; Scadding G; Senior B; Tomazic PV; Toskala E; Van Zele T; Viskens AS; Wagenmann M; Fokkens WJ
Allergy; 2024 May; 79(5):1123-1133. PubMed ID: 38108602
[TBL] [Abstract][Full Text] [Related]
37. Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis.
Fokkens W; Van Der Lans R; Reitsma S
Expert Opin Biol Ther; 2021 May; 21(5):575-585. PubMed ID: 33724109
[No Abstract] [Full Text] [Related]
38. Biologics for chronic rhinosinusitis with nasal polyps (CRSwNP).
Scadding GK; Scadding GW
J Allergy Clin Immunol; 2022 Mar; 149(3):895-897. PubMed ID: 34752829
[No Abstract] [Full Text] [Related]
39. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management.
Bachert C; Han JK; Wagenmann M; Hosemann W; Lee SE; Backer V; Mullol J; Gevaert P; Klimek L; Prokopakis E; Knill A; Cavaliere C; Hopkins C; Hellings P
J Allergy Clin Immunol; 2021 Jan; 147(1):29-36. PubMed ID: 33227318
[TBL] [Abstract][Full Text] [Related]
40. A survey on chronic rhinosinusitis: opinions from experts of 50 countries.
Passali D; Cingi C; Cambi J; Passali F; Muluk NB; Bellussi ML
Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2097-109. PubMed ID: 26742909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
